Posted by Michael Wonder on 14 Aug 2019
Drug company Aspen may pay NHS £8 million after investigation alleges illegal deal to hike drug price
14 August 2019 - The drug company Aspen may have to pay the NHS £8 million (€8.7 million ; $9.7 million) after an investigation by the Competition and Markets Authority into an arrangement it made with two rival companies, which left it as the sole supplier of a drug and therefore able to set prices without competition.
The Authority suspected that the 2016 arrangement had broken competition law, as Aspen was believed to have paid competitors to stay out of the market.
The drug in question—fludrocortisone acetate (100 mcg tablets)—is mainly used to treat Addison’s disease.
